Home > Press > New technology can detect hundreds of proteins in a single sample: Improvement of barcoding technique offers cost-effective alternative to current technology
Abstract:
New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.
Proteins found in blood provide scientists and clinicians with key information on our health. These biological markers can determine if a chest pain is caused by a cardiac event or if a patient has cancer.
Unfortunately, the tools used to detect such proteins haven’t evolved much over the past 50 years – despite there being over 20,000 proteins in our body, the vast majority of protein tests run today target only a single protein at-a-time.
Now, PhD candidate Milad Dagher, Professor David Juncker and colleagues in McGill’s Department of Biomedical Engineering have devised a technique that can detect hundreds of proteins with a single blood sample.
Part of their work, just published in Nature Nanotechnology, describes a new and improved way to barcode micro-beads using multicolour fluorescent dyes. By generating upwards of 500 differently coloured micro-beads, their new barcoding platform enables detection of markers in parallel from the same solution—for example, a blue barcode can be used to detect marker 1, while a red barcode can detect marker 2, and so on. A laser-based instrument called a cytometer then counts the proteins that stick to the different coloured beads.
Though this kind of analysis method has been available for some time, interference among multicolour dyes has limited the ability to generate the right colours. Now, a new algorithm developed by the team enables different colours of micro-beads to be generated with high accuracy—much like a colour wheel can be used to predict the outcome of colour mixing.
Professor Juncker’s team is hoping to leverage its platform for improved analysis of proteins.
“Current technologies hold a major trade-off between the number of proteins that can be measured at once, and the cost and accuracy of a test”, Dagher explains. “This means that large-scale studies, such as clinical trials, are underpowered because they tend to fall back on tried-and-true platforms with limited capabilities.”
Their upcoming work focuses on maintaining accurate detection of proteins with increased scale.
Dagher and Jeffrey Munzar, a postdoctoral fellow in the Juncker lab, have teamed up with Professor Juncker and spun-off a company, nplex biosciences, to commercialize their new approach.
The McGill group was also recently awarded an NSERC Idea to Innovation grant to support the development of the next version of their technology platform.
The authors thank NSERC and FQRNT for funding. M.D. acknowledges the NSERC-CREATE ISS programme for support. The flow cytometry work was performed at two McGill core flow facilities, namely the Microbiology and Immunology (MIMM) department and the Life Science Complex, which is supported by funding from the Canadian Foundation for Innovation.
####
For more information, please click here
Contacts:
Justin Dupuis
Media Relations
McGill University
Tel.: 514 398-6751
http://www.mcgill.ca/newsroom/
http://www.twitter.com/mcgillu
Copyright © McGill University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
Imaging
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Cancer
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||